Q4 2020 Marinus Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Marinus Pharmaceuticals Fourth Quarter 2020 Financial Results. (Operator Instructions) I would now like to turn the call over to Sasha Damouni, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Thank you, and good morning, everyone. With me from Marinus are Dr. Scott Braunstein, Chief Executive Officer; Dr. Joe Hulihan, Chief Medical Officer; Dr. Alex Aimetti, Vice President of Scientific Affairs; Ed Smith, Chief Financial Officer. Also on the call to participate in the Q&A is Christy Shafer, our Chief Commercial Officer; and Kimberly McCormick, Vice President of Regulatory Affairs.
Before we begin, I would like to remind everyone that some of the statements made today could be termed as forward-looking under the securities laws. These forward-looking statements are subject to certain risks and uncertainties that are associated with our business and covered in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |